Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes
NCT ID: NCT01964703
Last Updated: 2013-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
29 participants
INTERVENTIONAL
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
No interventions assigned to this group
Rubus occidentalis extract 900mg
taking Rubus occidentalis extract 900mg/day for 12weeks
Rubus occidentalis extract
Rubus occidentalis extract 1800mg
taking Rubus occidentalis extract 1800mg/day for 12weeks
Rubus occidentalis extract
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rubus occidentalis extract
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* prediabetes (fasting plasma glucose 100-125mg/dl, and/or post 75g OGTT plasma glucose 140-199mg/dl)
Exclusion Criteria
* taking anti-hyperglycemic agents within 3 months at the time of enrollment
* history of heart failure, myocardial infarction, cerebral infarction
* uncontrolled hypertension (systolic BP \> 160mmHg, or diastolic BP \> 100mmHg)
* serum triglyceride level \> 500mg/dl
* kidney dysfunction (serum Creatinine \> 30% of upper normal limits)
* hepatic dysfunction (AST, ALT \> 3 times of upper normal limits)
* taking systemic glucocorticoids within 1 month
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University Anam Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sin Gon Kim
Professor
References
Explore related publications, articles, or registry entries linked to this study.
An JH, Kim DL, Lee TB, Kim KJ, Kim SH, Kim NH, Kim HY, Choi DS, Kim SG. Effect of Rubus Occidentalis Extract on Metabolic Parameters in Subjects with Prediabetes: A Proof-of-concept, Randomized, Double-blind, Placebo-controlled Clinical Trial. Phytother Res. 2016 Oct;30(10):1634-1640. doi: 10.1002/ptr.5664. Epub 2016 Jun 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ED13024
Identifier Type: -
Identifier Source: org_study_id